Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy

Overview of attention for article published in Transplant International, April 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 35 X posts from 28 X users, with an upper bound of 63,231 followers.

RT @Transpl_Int: Conversion from #CNI to #belatacept, as rescue therapy post #KidneyTransplant, is safe and beneficial, irrespective of swi…

RT @MorelAntoine9: Very happy to share our last article suggesting that Conversion from CNI to #belatacept, as rescue therapy, is safe and…

RT @Transpl_Int: Conversion from #CNI to #belatacept, as rescue therapy post #KidneyTransplant, is safe and beneficial, irrespective of swi…

RT @Transpl_Int: Conversion from #CNI to #belatacept, as rescue therapy post #KidneyTransplant, is safe and beneficial, irrespective of swi…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 31 additional X posts.